Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Franken, I.H.A
2002.
Prevalencia del uso de MDMA (éxtasis) y neurotoxicidad.
European psychiatry (Ed. Española),
Vol. 9,
Issue. 3,
p.
202.
Maxwell, Jane Carlisle
2003.
The response to club drug use.
Current Opinion in Psychiatry,
Vol. 16,
Issue. 3,
p.
279.
Maxwell, Jane
2003.
Current Opinion in Psychiatry,
Vol. 16,
Issue. 3,
p.
279.
Vecellio, Marco
Schopper, Christian
and
Modestin, Jiri
2003.
Neuropsychiatric Consequences (Atypical Psychosis and Complex-Partial Seizures) of Ecstasy Use: Possible Evidence for Toxicity-Vulnerability Predictors and Implications for Preventative and Clinical Care.
Journal of Psychopharmacology,
Vol. 17,
Issue. 3,
p.
342.
López-Muñoz, F.
Rubio, G.
González-Martínez, E.
and
Álamo, C.
2004.
Éxtasis (3,4-metilendioximetanfetamina, MDMA): aspectos farmacológicos, clínicos y criminológicos.
Trastornos Adictivos,
Vol. 6,
Issue. 1,
p.
16.
Maxwell, Jane Carlisle
2005.
Party Drugs: Properties, Prevalence, Patterns, and Problems.
Substance Use & Misuse,
Vol. 40,
Issue. 9-10,
p.
1203.
Kuypers, Kim P.C.
Bosker, Wendy M.
and
Ramaekers, Johannes G.
2009.
Drugs, Driving and Traffic Safety.
p.
501.
Comments
No Comments have been published for this article.